Payment overview · 2025
General Payments
$101,190.23
102 reported records · 27 companies
Healthcare provider profile · identity verified
Mahmood Kafaii Razavi, M.D.
Allopathic & Osteopathic Physicians|Radiology|Vascular & Interventional Radiology · ORANGE, CA · NPI 1851388607
Verified facts
What the public records show
CMS Open Payments records show Mahmood Kafaii Razavi, M.D. received $101,190.23 in general payments during 2025 across 102 reported records.
Merit Medical Systems Inc accounted for 25.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 34 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Merit Medical Systems Inc | Unresolved — no canonical attribution shown | $25,856.72 | 25.6% | 11 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $16,248.27 | 16.1% | 18 | 2025 |
| MicroVention, Inc. | Unresolved — no canonical attribution shown | $13,426.68 | 13.3% | 3 | 2025 |
| Sirtex Medical Inc | Unresolved — no canonical attribution shown | $9,399.35 | 9.3% | 7 | 2025 |
| Terumo Medical Corporation | Unresolved — no canonical attribution shown | $6,950.00 | 6.9% | 6 | 2025 |
| Reflow Medical Inc | Unresolved — no canonical attribution shown | $6,325.64 | 6.2% | 5 | 2025 |
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $6,129.65 | 6.1% | 3 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $5,625.00 | 5.6% | 2 | 2025 |
| Philips North America LLC | Unresolved — no canonical attribution shown | $3,391.94 | 3.4% | 4 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $2,495.30 | 2.5% | 3 | 2025 |
| Recor Medical Inc | Unresolved — no canonical attribution shown | $1,895.79 | 1.9% | 14 | 2025 |
| Surmodics, Inc. | Unresolved — no canonical attribution shown | $1,703.45 | 1.7% | 3 | 2025 |
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $453.20 | 0.5% | 6 | 2025 |
| Endologix LLC | Unresolved — no canonical attribution shown | $429.42 | 0.4% | 2 | 2025 |
| INSTYLLA, INC. | Unresolved — no canonical attribution shown | $166.67 | 0.2% | 1 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $133.33 | 0.1% | 1 | 2025 |
| Avantec Vascular Corporation | Unresolved — no canonical attribution shown | $121.65 | 0.1% | 1 | 2025 |
| ARGON MEDICAL DEVICES, INC. | Unresolved — no canonical attribution shown | $94.38 | 0.1% | 1 | 2025 |
| Balt USA, LLC | Unresolved — no canonical attribution shown | $84.56 | 0.1% | 1 | 2025 |
| MIMEDX Group, Inc. | Unresolved — no canonical attribution shown | $46.30 | 0.1% | 1 | 2025 |
| CARDIVA MEDICAL, INC. | Unresolved — no canonical attribution shown | $40.91 | 0.0% | 2 | 2025 |
| Imperative Care, Inc | Unresolved — no canonical attribution shown | $40.90 | 0.0% | 2 | 2025 |
| CORDIS US CORP. | Unresolved — no canonical attribution shown | $33.53 | 0.0% | 1 | 2025 |
| InspireMD Ltd | Unresolved — no canonical attribution shown | $28.27 | 0.0% | 1 | 2025 |
| Nipro Medical Corporation | Unresolved — no canonical attribution shown | $26.71 | 0.0% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $23.18 | 0.0% | 1 | 2025 |
| Becton, Dickinson and Company | Unresolved — no canonical attribution shown | $19.43 | 0.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $87,161.74 | 33 |
| Long term medical supply or device loan | $6,000.00 | 1 |
| Travel and Lodging | $4,030.22 | 16 |
| Food and Beverage | $3,459.84 | 51 |
| Acquisitions | $538.43 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| General - Therapies Normalized: general therapies |
Device | Boston Scientific Corporation | $14,644.27 | 10 | 2025 |
Source payment records
|
|||||
| Wrapsody Stent Graft Normalized: wrapsody stent graft |
Device | Merit Medical Systems Inc | $10,472.64 | 6 | 2025 |
Source payment records
|
|||||
| LAVA LES (Liquid Embolic System) Normalized: lava les liquid embolic system |
Device | Sirtex Medical Inc | $9,262.29 | 6 | 2025 |
Source payment records
|
|||||
| AURYON LASER SYSTEM 100-120 VAC Normalized: auryon laser system 100 120 vac |
Device | AngioDynamics, Inc. | $6,102.56 | 2 | 2025 |
Source payment records
|
|||||
| IGT Devices Undivided Normalized: igt devices undivided |
Device | Philips North America LLC | $3,391.94 | 4 | 2025 |
Source payment records
|
|||||
| Product in Development Normalized: product in development |
Device | W. L. Gore & Associates, Inc. | $2,445.12 | 2 | 2025 |
Source payment records
|
|||||
| Paradise Ultrasound Renal Denervation System Normalized: paradise ultrasound renal denervation system |
Device | Recor Medical Inc | $1,895.79 | 14 | 2025 |
Source payment records
|
|||||
| Sublime 014 Rx PTA Balloon Dilatation Catheter Normalized: sublime 014 rx pta balloon dilatation catheter |
Device | Surmodics, Inc. | $1,703.45 | 3 | 2025 |
Source payment records
|
|||||
| Sublime Microcatheter, 018, 200cm, Straight Normalized: sublime microcatheter 018 200cm straight |
Device | Surmodics, Inc. | $1,703.45 | 3 | 2025 |
Source payment records
|
|||||
| JETSTREAM SC Normalized: jetstream sc |
Device | Boston Scientific Corporation | $1,585.31 | 6 | 2025 |
Source payment records
|
|||||
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $453.20 | 6 | 2025 |
Source payment records
|
|||||
| ENDOCROSS Device Normalized: endocross device |
Device | Endologix LLC | $429.42 | 2 | 2025 |
Source payment records
|
|||||
| Torus Stent Graft System Normalized: torus stent graft system |
Device | Endologix LLC | $429.42 | 2 | 2025 |
Source payment records
|
|||||
| EMBRACE HYDROGEL EMBOLIC SYSTEM (HES) Normalized: embrace hydrogel embolic system hes |
Device | INSTYLLA, INC. | $166.67 | 1 | 2025 |
Source payment records
|
|||||
| INSTYLLA DELIVERY KIT Normalized: instylla delivery kit |
Device | INSTYLLA, INC. | $166.67 | 1 | 2025 |
Source payment records
|
|||||
| INSTYLLA MICROCATHETER 1.2 Normalized: instylla microcatheter 1 2 |
Device | INSTYLLA, INC. | $166.67 | 1 | 2025 |
Source payment records
|
|||||
| SIR-Spheres Microspheres Normalized: sir spheres microspheres |
Device | Sirtex Medical Inc | $137.06 | 1 | 2025 |
Source payment records
|
|||||
| Penumbra System Normalized: penumbra system |
Device | Penumbra, Inc. | $133.33 | 1 | 2025 |
Source payment records
|
|||||
| CLOT MANAGEMENT Normalized: clot management |
Device | ARGON MEDICAL DEVICES, INC. | $94.38 | 1 | 2025 |
Source payment records
|
|||||
| Prestige Coil System Normalized: prestige coil system |
Device | Balt USA, LLC | $84.56 | 1 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy Normalized: pounce thrombectomy |
Device | Surmodics, Inc. | $53.45 | 2 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy System Normalized: pounce thrombectomy system |
Device | Surmodics, Inc. | $53.45 | 2 | 2025 |
Source payment records
|
|||||
| Pounce Venous Thrombectomy System Normalized: pounce venous thrombectomy system |
Device | Surmodics, Inc. | $53.45 | 2 | 2025 |
Source payment records
|
|||||
| EXCLUDER Conformable AAA Endoprosthesis with Active Control Normalized: excluder conformable aaa endoprosthesis with active control |
Device | W. L. Gore & Associates, Inc. | $50.18 | 1 | 2025 |
Source payment records
|
|||||
| CARDIVA VASCADE MVP VVCS 6-12F Normalized: cardiva vascade mvp vvcs 6 12f |
Device | CARDIVA MEDICAL, INC. | $40.91 | 2 | 2025 |
Source payment records
|
|||||
| MYNX CONTROL VENOUS Normalized: mynx control venous |
Device | CORDIS US CORP. | $33.53 | 1 | 2025 |
Source payment records
|
|||||
| CGuard Prime Carotid Stent System Normalized: cguard prime carotid stent system |
Device | InspireMD Ltd | $28.27 | 1 | 2025 |
Source payment records
|
|||||
| ALPHAVAC Normalized: alphavac |
Device | AngioDynamics, Inc. | $27.09 | 1 | 2025 |
Source payment records
|
|||||
| Hemodialysis System Normalized: hemodialysis system |
Device | Nipro Medical Corporation | $26.71 | 1 | 2025 |
Source payment records
|
|||||
| SYMPHONY CATHETER Normalized: symphony catheter |
Device | Imperative Care, Inc | $25.77 | 1 | 2025 |
Source payment records
|
|||||
| PERCLOSE PROSTYLE Normalized: perclose prostyle |
Device | Abbott Laboratories | $23.18 | 1 | 2025 |
Source payment records
|
|||||
| COVERA Normalized: covera |
Device | Becton, Dickinson and Company | $19.43 | 1 | 2025 |
Source payment records
|
|||||
| Ranger Normalized: ranger |
Device | Boston Scientific Corporation | $18.69 | 2 | 2025 |
Source payment records
|
|||||
| PRODIGY CATHETER Normalized: prodigy catheter |
Device | Imperative Care, Inc | $15.13 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $101,190.23 · 102 records | Merit Medical Systems Inc | ALPHAVAC, AURYON LASER SYSTEM 100-120 VAC, CARDIVA VASCADE MVP VVCS 6-12F, CGuard Prime Carotid Stent System, CLOT MANAGEMENT, COVERA, EMBRACE HYDROGEL EMBOLIC SYSTEM (HES), ENDOCROSS Device, EXCLUDER Conformable AAA Endoprosthesis with Active Control, General - Therapies, Hemodialysis System, IGT Devices Undivided, INSTYLLA DELIVERY KIT, INSTYLLA MICROCATHETER 1.2, JETSTREAM SC, LAVA LES (Liquid Embolic System), MYNX CONTROL VENOUS, PERCLOSE PROSTYLE, PRODIGY CATHETER, Paradise Ultrasound Renal Denervation System, Penumbra System, Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Prestige Coil System, Product in Development, Ranger, SIR-Spheres Microspheres, SYMPHONY CATHETER, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, Sublime 014 Rx PTA Balloon Dilatation Catheter, Sublime Microcatheter, 018, 200cm, Straight, Torus Stent Graft System, Wrapsody Stent Graft | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error